Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

Go back to Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
Labranche & Co (NASDAQ: LAB) Delayed: 0.65 --0 (-0%)
Previous Close $0.65    52 Week High $4.47 
Open $0.65    52 Week Low $3.02 
Day High $0.66    P/E N/A 
Day Low $0.64    EPS $-1.56 
Volume 1,337,255